Recruiting
Rectal cancer
RecruitingInvestigationalNo placebo
Evaluating SGM-101 (fluorochrome-labeled antibody) in patients with locally advanced or recurrent rectal cancer undergoing surgery
InvestigationalNo placebo
- Disease:Rectal cancer
- Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104







